---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-011419"
form_type: "8-K"
ticker: "PCSA"
cik: "0001533743"
company_name: "Processa Pharmaceuticals, Inc."
filed_at: "2025-07-25T23:59:59+00:00"
generated_at: "2026-05-18T01:07:48.670046+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Processa Pharmaceuticals files prospectus supplement to sell up to $5.2 million shares of common stock

## Summary
- On July 25, 2025, Processa filed a prospectus supplement to its Form S-3 (Registration No. 333-279588) for an equity distribution agreement with A.G.P./Alliance Global Partners.
- The supplement permits the sale of $5,239,073 shares of common stock, with $1,546,338 shares already sold in the prior 12 months.
- As of the prospectus supplement date, $3,692,735 shares remain available for sale under the agreement.
- The offering is conducted via an at-the-market equity distribution agreement with A.G.P./Alliance Global Partners.

## SEC filing metadata
- accession: 0001493152-25-011419
- form_type: 8-K
- ticker: PCSA
- cik: 0001533743
- company_name: Processa Pharmaceuticals, Inc.
- filed_at: 2025-07-25T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533743/000149315225011419/0001493152-25-011419-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533743/000149315225011419/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-011419
- JSON: https://secwatch.observer/filing/0001493152-25-011419.json
- Plain text: https://secwatch.observer/filing/0001493152-25-011419.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.